FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
Loading...

Aarti Drugs Ltd Buyback Mar 2019

Rated 2/5 by Team InvestorGain

What is the Aarti Drugs Ltd share buyback offer?

Mar 15th, 2019: Aarti Drugs Ltd (BSE:524348 | NSE:AARTIDRUGS) board has approved a proposal for buyback of up to 2.82 lakh shares at Rs 900 per share, aggregating Rs 25.38 Cr (Buyback Offer Size) which is 5.51% of total paid-up equity share capital.

What is Aarti Drugs Ltd Buyback details?

Below is the complete details about Aarti Drugs Ltd Buyback. Record date, buyback open and close dates are announce in below section.

Buyback Type: Tender Offer
Buyback Offer Amount: Rs 25.38 Cr
Buyback Number of Shares: 2.82 lakhs
Buyback Price: Rs 900
Buyback Offer Size (In %): 5.51%
Total Share Capital: Rs 1,552.88 Cr
Face Value: 10 Per Equity Share

Can I Invest today to participate in Aarti Drugs Ltd buyback offer? No

Recommendation

We don't recommend for Aarti Drugs Buyback as acceptance ration for the retail investor will be below 10%. We rated Aarti Drugs Buyback as 2.0/5 (Poor). Last year also in retail category acceptance ratio was 3% to 4% on 24 Cr buyback(2.6 lakh shares), so we are not expecting any big change in AR. For existing investor of Aarti Drugs, this is a good premium. New retail investor should avoid.

Rating

Poor (<10% AR),Fair (Bw 11 to 30% AR), Average (Bw 30 to 60% AR), Good (Bw 60 to 90% AR),Excellent (>90% AR)

What are Aarti Drugs Ltd Buyback Important Dates?

In this section we have covered all important dates related to Aarti Drugs Ltd Buyback. Dates are updated as they are announced. The most noted dates are record date and buyback open and close dates, which one should use to participate in buyback.

Aarti Drugs Ltd buyback offer important dates
Buyback Activity Date
Board Meeting for Buyback proposal 15th Mar 2019
Buyback Approval date 18th Mar 2019
Public Announcement of Buyback 19th Mar 2019
Record Date 29th Mar 2019
Buyback opens on/Buyback Opening Date 3rd May 2019
Buyback closes on/Buyback Closing Date 16th May 2019
Cut-off date to receive completed tender forms by Registrar 18th May 2019
Cut-off date for verification by the Registrar 24th May 2019
Cut-off date to inform Stock Exchange on acceptance or non-acceptance
of tendered Equity Shares by Registrar
24th May 2019
Last date of settlement of bids on the stock exchange 27th May 2019
Last date to return unaccepted shares by Registrar 27th May 2019
Last date of extinguishment of Equity Shares 3rd Jun 2019

Aarti Drugs Ltd Share Holding Pattern as of Dec 2018

Stock Holding table gives a clear picture on retail investor holdings of Aarti Drugs Ltd shares which helps investor to decide on participating in buyback offer. The less number of retail holdings means higher chance of acceptance in buyback under retail category which is equal to higher profit.

Holding Type In %
Promoter-Foreign 0.0%
Promoter-Indian 62.30%
Non-Promoter-Institutions 5.40%
Non-Promoter-Non-Institutions 32.30%

Aarti Drugs Ltd Public Announcement >>Document

Aarti Drugs Ltd Draft Letter of Offer >>Document

Aarti Drugs Ltd Post Buyback Public Announcement >>Document

Aarti Drugs Ltd Ratio of Buyback

    For Buy back shares holders are divided in 2 categories:
  • Reserved category for Small Shareholders ("Reserved Category") - Who holds Max Rs 2 Lakhs worth of shares @Rs 637.30 per equity share - in such case Max 313 Equity Shares as of Record Date 29th Mar 2019.
  • General category for all Shareholders other than Small Shareholders ("General Category")

Aarti Drugs Ltd Ratio of Buy Back

Category Entitlement Ratio of Buyback Per Equity Shares Entitlement Ratio of Buyback in %
Reserved Category 3 Equity Share out of every 115 fully paid-up Equity Share held on the Record Date. 2.63%
General Category 3 Equity Share out of every 275 fully paid-up Equity Share held on the Record Date. 1.09%

Post buyback comments Aarti Drugs Ltd

For Aarti Drugs Ltd Buyback Offer, Report updated by the manager of buyback -

In general category - response received 6929.61%, No. of Equity Shares reserved in Buyback was 239785 where valid bid received for retail category was 16615288 which is 6929.61% oversubscribed.

In Reserved category for Small Shareholders (Retail) - response received only 1358.75%, No. of Equity Shares reserved in Buyback was 42315 where valid bid received for retail category was 574796 which is 1358.75%. Final Acceptance Ratio for Retail Investors was 2.63%.

As per our initial estimate number of tender shares was too high, so the acceptance ratio for retail investors was very poor.

Current and Upcoming Buybacks Key dates

The table below will give you a complete dashboard view for all open buyback offer in current market.

Current and Upcoming Buybacks Key dates
Company NameBuyback TypeOffer AmountBuyback PriceCMPRecord DateBuyback Open DateBuyback End Date
Tanla Platforms LtdTender OfferRs 170 Cr1200966.40 (-1.91%)25-10-2022TBDTBD
Garware Technical Fibres LtdTender OfferRs 90 Cr37504-11-2022TBDTBD
Orbit Exports LimitedTender OfferRs 10 Cr245180.00 (6.48%)18-11-2022TBDTBD
KRBL LimitedTender Offer₹325.00Cr500299.20 (1.00%)25-08-2023TBDTBD
Tips Industries LimitedTender Offer₹37.19Cr625460.95 (-0.25%)22-04-202426-04-202403-05-2024

Detail Article on Benefit from buyback offer >> Read

Aarti Drugs Ltd Buyback Important dates - Record Date,Buyback Start and End date. Buyback Details - Buyback Price, Buyback Offer Size, Buyback Number of Shares, Retail Investors limit. What is the record date for Aarti Drugs Ltd? How can I apply in Aarti Drugs Ltd Buyback offer?

Company Contact Information

Aarti Drugs Ltd
Plot No. N-198,
MIDC, Tarapur, ,Village - Pamtermbhi,
Palghar District
Maharashtra -401506
Email: [email protected]
Website: http://www.aartidrugs.com

Registrar Contact Information

Link Intime India Pvt. Ltd. C 101, 247 Park,
L.B.S. Marg, Vikhroli (West)
Mumbai - 400083
Maharashtra
Email: [email protected]
Website: http://www.linkintime.co.in

Last Updated on 2019-06-03T11:25:51+00:00

Request call back from

User Reviews

2. S.B.Maheshwari Apr 02 2019 10:41:59 AM Reply
Record date has been announced. kindly update
1. Shriyansh Singh Mar 18 2019 04:34:26 PM Reply
Last year buyback of Aarti Drugs - Acceptance ratio was 3%, so the retail investor should ignore this.